Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., . . . Soubrié, P. (2002). Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V(1b) receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. The National Academy of Sciences.

Griebel, Guy, Jacques Simiand, Claudine Serradeil-Le Gal, Jean Wagnon, Marc Pascal, Bernard Scatton, Jean-Pierre Maffrand, und Philippe Soubrié. Anxiolytic- and Antidepressant-like Effects of the Non-peptide Vasopressin V(1b) Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-related Disorders. The National Academy of Sciences, 2002.

Griebel, Guy, et al. Anxiolytic- and Antidepressant-like Effects of the Non-peptide Vasopressin V(1b) Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-related Disorders. The National Academy of Sciences, 2002.